FM
BDSI

Fondren Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Fondren Management’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200,000
Closed -$560K – 113
2018
Q3 		$560K Sell
200,000
-30,180
-13% -$84.7K 0.5% 42
2018
Q2 		$679K Buy
+230,180
New +$546K 0.52% 50

Other funds holding BDSI

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AOWM
Alpha Omega Wealth Management Richmond, Virginia $617M AUM 16.56% 1-Year Est. Return

Fondren Management's BDSI Position: Q4 2018 in Review

Fondren Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2018, closing a stake of 200,000 shares — an estimated $560K sold.

Fondren Management first reported a position in BDSI in Q2 2018 and held it in 2 quarters. The position peaked at $679K in Q2 2018. 86 funds tracked by Wall St. Rank hold BDSI as of Q4 2018.

  • Fondren Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2018 after selling out during the quarter.
  • Fondren Management sold 200,000 BioDelivery Sciences International, Inc. shares in Q4 2018, an estimated $560K.
  • Fondren Management first reported a position in BioDelivery Sciences International, Inc. in Q2 2018 and held it in 2 quarters.
  • Fondren Management's BioDelivery Sciences International, Inc. position peaked at $679K in Q2 2018.
  • 86 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2018.

Based on Fondren Management's 13F filing for Q4 2018, filed 14 Feb 2019.